COUFAL SANDRA I

About COUFAL SANDRA I

Sandra I. Coufal, M.D., is a healthcare and life-sciences executive whose best-documented connection to Tricida, Inc. is as a board member. Publicly available profiles describe her as a physician by training and a seasoned biotech entrepreneur, with board-level experience at Tricida, a U.S.-listed company in the pharmaceutical sector. Her broader current leadership profile also identifies her as Chief Executive Officer of Toragen, Inc. and President of Sibling Capital LLC, indicating a career that spans operating leadership, company building, and strategic oversight. ([quotes.sina.com.cn](https://quotes.sina.com.cn/usstock/hq/officers.php?s=TCDA&utm_source=openai)) Her earlier career reflects a strong clinical foundation. Available sources place her in leadership within internal medicine at Scripps Clinic Medical Group and also link her to operational roles at Ilypsa, Inc. and Relypsa, Inc. She is also described as a founder of Relypsa, which is a significant marker of entrepreneurial experience in the biotechnology ecosystem. Taken together, these roles suggest that her professional path has moved from medicine into company formation, executive management, and governance. ([quotes.sina.com.cn](https://quotes.sina.com.cn/usstock/hq/officers.php?s=TCDA&utm_source=openai)) Sandra Coufal’s expertise appears to sit at the intersection of clinical practice, scientific innovation, and board governance. One profile summarizes her as having more than 30 years of experience across medicine and entrepreneurship, with work touching biotechnology, chemistry, materials science, and digital technology. That breadth is especially relevant in board and advisory settings, where executives are expected to assess research programs, strategic priorities, regulatory risk, and long-term value creation. ([people.equilar.com](https://people.equilar.com/bio/person/sandra-coufal-toragen/21683502?utm_source=openai)) Her notable contributions are best characterized as leadership in building and guiding innovation-driven companies rather than as a single publicly documented decision. In the Tricida context, the sources confirm her as a director and insider, but they do not provide detailed evidence of specific board decisions attributable to her alone. For SEO and corporate biography use, the most accurate description is therefore a careful, professional summary: a physician-entrepreneur, biotech founder, and governance professional with experience supporting science-led companies through growth and strategic transition. ([quotes.sina.com.cn](https://quotes.sina.com.cn/usstock/hq/officers.php?s=TCDA&utm_source=openai))